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Identifying Medullary Thyroid Carcinoma
Biomarkers
There exists a genotype-phenotype correlation with speciﬁc
germline RET mutations in medullary thyroid carcinoma
(MTC), but the pathways involved remain unknown. Malis-
zewska et al (Am J Pathol 2013, 182:350e362) used tran-
scriptional proﬁling to identify signaling pathways and speciﬁc
biomarkers related to familial (PROM1, LOXL2, GFRA1, and
DKK4 associated with RETM918T) and sporadic MTC (GAL
associated with RET634). Genes associated with MTCM918T
were mainly involved in proliferative, cell adhesion, and
general malignant metastatic effects, as well as Wnt, Notch,
NFkB, JAK/Stat, and MAP kinase signaling pathways.
SilencingPROM1 via siRNAcells harboringRETM918T caused
an increase in apoptotic nuclei, suggesting that PROM1 is
necessary for the survival of these cells. These data identify
new therapeutic targets to improve MTC management.
miR-199a-5p Regulates Urothelial
Permeability in Bladder Pain Syndrome
Defects in urothelial integrity resulting in leakage and
activation of underlying sensory nerves are potential caus-
ative factors of bladder pain syndrome, a clinical syndrome
of idiopathic pelvic pain and urinary urgency/frequency.
Monastyrskaya et al (Am J Pathol 2013, 182:431e448)
identiﬁed rmiR-199a-5p as an important regulator of inter-
cellular integrity. Upon overexpression in urothelial and
bronchial epithelial cells, miR-199a-5p impaired tight
junction formation and led to increased epithelial perme-
ability. miR-199a-5p directly targeted mRNAs encoding
LIN7C, ARHGAP12, PALS1, RND1, and PVRL1 and
attenuated their expression levels to a similar extent. The
data demonstrate for the ﬁrst time that miRNA expression
inﬂuences urothelial permeability and might underlie the
changes in bladder urothelium observed in bladder pain
syndrome.
PPARg in Prostate Differentiation
Stromal-epithelial interactions are crucial for the develop-
ment of hind gut-derived endoderm into rectal, prostatic,Copyright ª 2013 American Society for Investigative Pathology.
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http://dx.doi.org/10.1016/j.ajpath.2012.12.001and bladder phenotypes; however, the precise mechanisms
by which epithelium responds to stromal cues remain
unknown. Strand et al (Am J Pathol 2013, 182:449e459)
examined the role of proliferator activated receptor gamma g
(PPARg) isoforms and PTEN activity in prostate differ-
entiation. Knockdown experiments demonstrated that
PPARg2 is essential for urothelial transdifferentiation.
Knockdown of both PPARg isoforms 1 and 2 arrested uro-
thelial differentiation of benign human prostate epithelial
(BHPrE) cells. Although PTEN deﬁciency alone induced
latent squamous differentiation in BHPrE cells, combined
PPARg and PTEN deﬁciency accelerated the development of
keratinizing squamous metaplasia. These data suggest a role
for the regulation of epithelial cellular metabolism in the
process of differentiation.Tamoxifen Ameliorates Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is characterized by
progressive muscle wasting, respiratory and cardiac impair-
ments, and premature death. Using the mdx5Cv mouse model
of DMD, Dorchies et al (Am J Pathol 2013, 182:485e504)
identiﬁed tamoxifendused to treat estrogen-dependent
breast cancerdas helpful in DMD therapy. Oral tamoxifen
treatment stabilized myoﬁber membranes, normalized whole
body force, and increased force production and resistance to
repeated contractions of the triceps muscle. Tamoxifen also
improved the structure of leg muscles, diminished cardiac
ﬁbrosis, and reduced diaphragm ﬁbrosis, while increasing its
thickness, myoﬁber count, and myoﬁber diameter and
conferred a markedly slower phenotype to the muscles.
Interestingly, estrogen receptors (ERs) a and b were signif-
icantly increased in dystrophic compared to normal muscles,
and tamoxifen normalized the relative abundance of ERb
isoforms. These ﬁndings suggest that tamoxifen might be
a useful therapy for DMD.Optimizing Macrophages for Muscle Regrowth
Growing evidence suggests that macrophages possess major
myogenic capacities. Dumont et al (Am J Pathol 2013,
182:505e515) used in vivo and in vitro atrophy models to
investigate the impact of stimulating macrophages with
This Month in AJPmacrophage-colony stimulating factor (M-CSF) on muscle
regrowth. M-CSF signiﬁcantly increased the total macro-
phage density in soleus muscle and promoted a wound-
healing macrophage phenotype, better and faster muscle
ﬁber diameter, and function recovery. In vitro co-culture of290myotubes and macrophages conﬁrmed that the M-CSF-
induced switch in macrophage phenotype promoted myo-
tube growth by decreasing protein degradation. This study
establishes that macrophage myogenic capacities can be
modulated to optimize muscle recovery and regrowth.ajp.amjpathol.org - The American Journal of Pathology
